RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Health care resource utilization of patients with advanced gastric cancer/gastroesophageal junction cancer or esophageal adenocarcinoma
Results of nivolumab plus chemotherapy versus chemotherapy from checkmate 649
Xiao, H., Blum, S., Davenport, E., Wang, J., Hunter, S., Li , M., & Kondo, K. (2021). Health care resource utilization of patients with advanced gastric cancer/gastroesophageal junction cancer or esophageal adenocarcinoma: Results of nivolumab plus chemotherapy versus chemotherapy from checkmate 649. Journal of managed care & specialty pharmacy, 27(10-a), Article S19.